Search - tctmd.com

Displaying 221 - 236 of 236

Sort: Relevancy | Date

News Industry News

OrbusNeich’s COMBO™ Dual Therapy Stent Featured in TCT 2013 Satellite Symposium

October 31, 2013

News Daily News

ROCKET AF: Heart Failure Does Not Weaken the Case for Rivaroxaban

Caitlin E. Cox

June 20, 2013

News Daily News

Public Reporting of PCI Mortality May Have Unintended Consequences

June 20, 2013

News Conference News EuroPCR 2013

RIPCORD Study: FFR Results Change Path of Patient Management

Caitlin E. Cox

May 23, 2013

News Daily News

Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib

March 28, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Q&A

February 13, 2013

News Daily News

Indirect Comparisons Show Little Difference Among New Anticoagulants

August 14, 2012

News Daily News

Japanese Registry Confirms PCI, CABG ‘Comparable’ for Less Complex Left Main Disease

Caitlin E. Cox

June 28, 2012

News Industry News

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

May 14, 2012

News Daily News

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Caitlin E. Cox

May 09, 2012

News Features

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Caitlin E. Cox

May 07, 2012

News Industry News

ReCor Medical discloses new data from clinical study of its PARADISE™ ultrasound transcatheter renal denervation system for treating resistant hypertension

April 09, 2012

News Daily News

Off-Pump CABG Reduces Postoperative Stroke vs. Standard Surgery

October 12, 2011

News Industry News

Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study

August 15, 2011

News Daily News

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Jason Kahn

April 11, 2011

News Conference News

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

Caitlin E. Cox

April 03, 2011

Advertisement

OrbusNeich’s COMBO™ Dual Therapy Stent Featured in TCT 2013 Satellite Symposium

ROCKET AF: Heart Failure Does Not Weaken the Case for Rivaroxaban

Public Reporting of PCI Mortality May Have Unintended Consequences

RIPCORD Study: FFR Results Change Path of Patient Management

Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib

Conversations in Cardiology: Q&A

Indirect Comparisons Show Little Difference Among New Anticoagulants

Japanese Registry Confirms PCI, CABG ‘Comparable’ for Less Complex Left Main Disease

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

ReCor Medical discloses new data from clinical study of its PARADISE™ ultrasound transcatheter renal denervation system for treating resistant hypertension

Off-Pump CABG Reduces Postoperative Stroke vs. Standard Surgery

Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content